Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
2
DCVC, Lux Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Zymedi leverages ARS biology to discover novel therapeutics and first-in-class drugs for patients.
We will discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
Peptris is an AI-powered preclinical drug discovery company, leveraging cutting-edge technology to accelerate the discovery of novel…
Transcripta BioSeries A $24M · 2 mo ago • 51-200 employees
Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
Via Nova Therapeutics is committed to discovering novel therapies for viral diseases, especially those arising from acute & subacute…
Zus HealthVenture round $40M · 3 yr ago • Founded 2020 • 51-200 employees • 5 roles
Zus is the only shared health data platform designed to accelerate healthcare data interoperability by providing easy-to-use patient data…

Overview

Auransa is a clinical stage, AI-native biopharma with a proprietary AI platform that harnesses available human disease data to discover novel therapeutics and raise the standard of care for cancer.